It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Complex carbohydrates that escape small intestinal digestion, are broken down in the large intestine by enzymes encoded by the gut microbiome. This is a symbiotic relationship between microbes and host, resulting in metabolic products that influence host health and are exploited by other microbes. However, the role of carbohydrate structure in directing microbiota community composition and the succession of carbohydrate-degrading microbes, is not fully understood. In this study we evaluate species-level compositional variation within a single microbiome in response to six structurally distinct carbohydrates in a controlled model gut using hybrid metagenome assemblies. We identified 509 high-quality metagenome-assembled genomes (MAGs) belonging to ten bacterial classes and 28 bacterial families. Bacterial species identified as carrying genes encoding starch binding modules increased in abundance in response to starches. The use of hybrid metagenomics has allowed identification of several uncultured species with the functional potential to degrade starch substrates for future study.
Longitudinal hybrid metagenomic analyses of a human stool sample reveal compositional and functional variation in response to six structurally-distinct carbohydrates, providing insight into how gut bacteria utilize various carbohydrate sources.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Quadram Institute Bioscience, Norwich Research Park, Norwich, UK (GRID:grid.40368.39) (ISNI:0000 0000 9347 0159); Norwegian University of Science and Technology, Gemini centre for Sepsis Research, Department of Circulation and Medical Imaging, Trondheim, Norway (GRID:grid.5947.f) (ISNI:0000 0001 1516 2393)
2 Quadram Institute Bioscience, Norwich Research Park, Norwich, UK (GRID:grid.40368.39) (ISNI:0000 0000 9347 0159)
3 Quadram Institute Bioscience, Norwich Research Park, Norwich, UK (GRID:grid.40368.39) (ISNI:0000 0000 9347 0159); University of Kentucky, Department of Horticulture, Lexington, USA (GRID:grid.266539.d) (ISNI:0000 0004 1936 8438)
4 Quadram Institute Bioscience, Norwich Research Park, Norwich, UK (GRID:grid.40368.39) (ISNI:0000 0000 9347 0159); London School of Hygiene & Tropical Medicine, London, UK (GRID:grid.8991.9) (ISNI:0000 0004 0425 469X)
5 Quadram Institute Bioscience, Norwich Research Park, Norwich, UK (GRID:grid.40368.39) (ISNI:0000 0000 9347 0159); University of East Anglia, Norwich Research Park, Norwich, UK (GRID:grid.8273.e) (ISNI:0000 0001 1092 7967)